Catalio Capital Management Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 29

Professionals

  • Investments
  • 117

  • Portfolio
  • 67

  • Exits
  • 24

Exits

Catalio Capital Management General Information

Company Description

Founded in 2020, Catalio Capital Management is a venture capital firm based in New York, New York. The firm prefers to invest in companies operating in the biomedical technology sector. The firm invests in various asset classes like private equity, private credit and public equity. The firm employs a long bias, fundamental, bottoms-up equity and long/short strategy to invest. The firm is a Registered Investment Adviser (RIA).

Business Details

Website
www.cataliocapital.com
Formerly Known As
Nexus
Year Founded
2020
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Lender/Debt Provider
Growth/Expansion
Hedge Fund
Corporate Office
  • 512 West 22nd Street
  • 5th Floor
  • New York, NY 10011
  • United States
+1 (917)

Catalio Capital Management Investments (117)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Imbria Pharmaceuticals 10-Apr-2025 Later Stage VC Drug Discovery Clinical Trials - Phase 2
Pheast Therapeutics 10-Apr-2025 Drug Discovery Clinical Trials - Phase 1
Character Biosciences 20-Mar-2025 Drug Discovery Pre-Clinical Trials
Perceive Pharma 18-Feb-2025 Drug Discovery Startup
Aviceda Therapeutics 07-Jan-2025 Biotechnology Clinical Trials - Phase 2
Alentis Therapeutics 11-Nov-2024 Drug Discovery Clinical Trials - Phase 2
Orasis Pharmaceuticals 08-Oct-2024 Pharmaceuticals Clinical Trials - Phase 3
Superluminal Medicines 04-Sep-2024 Drug Discovery Generating Revenue
PrognomIQ 26-Aug-2024 Later Stage VC Biotechnology Generating Revenue
Odyssey Therapeutics 14-Aug-2024 Later Stage VC Biotechnology Generating Revenue/Not Profitable
You’re viewing 10 of 117 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Catalio Capital Management Exits (24)

Company Name Exit Date Exit Type Exit Size
Boost Neuroscience 19-Feb-2025 Merger/Acquisition
Sherlock Biosciences 19-Dec-2024
Protara Therapeutics 09-Dec-2024
Septerna 25-Oct-2024
Celsius Therapeutics 27-Jun-2024
Metagenomi 09-Feb-2024
Fractyl Health 02-Feb-2024
ArriVent Biopharma 26-Jan-2024
Pillar Biosciences 01-Jan-2024 Secondary Transaction - Private
Neumora 15-Sep-2023 IPO
You’re viewing 10 of 24 exits. Get the full list »

Catalio Capital Management Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Catalio Capital Management‘s full profile, request access.

Request a free trial

Catalio Capital Management Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Catalio Capital Management FAQs

  • What is Catalio Capital Management?

    Founded in 2020, Catalio Capital Management is a venture capital firm based in New York, New York.

  • When was Catalio Capital Management founded?

    Catalio Capital Management was founded in 2020.

  • Where is Catalio Capital Management headquartered?

    Catalio Capital Management is headquartered in New York, NY.

  • What is Catalio Capital Management's total asset value?

    Catalio Capital Management has around in total assets under management.

  • How many investments has Catalio Capital Management made?

    Catalio Capital Management has made 117 investments.

  • What has Catalio Capital Management invested in?

    Catalio Capital Management has made numerous investments in companies like Imbria Pharmaceuticals, Pheast Therapeutics, and Character Biosciences within the Drug Discovery industry.

  • What has Catalio Capital Management invested in recently?

    Catalio Capital Management's latest investment was on 10-Apr-2025 in Imbria Pharmaceuticals, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »